308 related articles for article (PubMed ID: 34439235)
21. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
[TBL] [Abstract][Full Text] [Related]
22. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.
Pang MF; Lin KW; Peh SC
Cell Mol Biol Lett; 2009; 14(2):222-47. PubMed ID: 19082921
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses.
Wang M; Yu F; Wu W; Wang Y; Ding H; Qian L
Int J Biol Sci; 2018; 14(5):565-576. PubMed ID: 29805308
[TBL] [Abstract][Full Text] [Related]
25. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death.
Lange PT; Damania B
mBio; 2023 Apr; 14(2):e0345922. PubMed ID: 36786572
[TBL] [Abstract][Full Text] [Related]
27. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma.
Zhang J; Huang T; Zhou Y; Cheng ASL; Yu J; To KF; Kang W
J Cell Mol Med; 2018 Jan; 22(1):38-45. PubMed ID: 28990284
[TBL] [Abstract][Full Text] [Related]
28. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
Neparidze N; Lacy J
Clin Adv Hematol Oncol; 2014 Jun; 12(6):358-71. PubMed ID: 25003566
[TBL] [Abstract][Full Text] [Related]
29. The lytic phase of Epstein-Barr virus plays an important role in tumorigenesis.
Liang Y; Zhang Y; Luo B
Virus Genes; 2023 Feb; 59(1):1-12. PubMed ID: 36242711
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer/T-Cell Lymphomas.
Li L; Ma BBY; Chan ATC; Chan FKL; Murray P; Tao Q
Pathogens; 2018 Jul; 7(3):. PubMed ID: 30022006
[No Abstract] [Full Text] [Related]
31. The role of Epstein-Barr virus in epithelial malignancies.
Tsao SW; Tsang CM; To KF; Lo KW
J Pathol; 2015 Jan; 235(2):323-33. PubMed ID: 25251730
[TBL] [Abstract][Full Text] [Related]
32. The hide-and-seek game of the oncogenic Epstein-Barr virus-encoded EBNA1 protein with the immune system: An RNA G-quadruplex tale.
Dinh VT; Loaëc N; Quillévéré A; Le Sénéchal R; Keruzoré M; Martins RP; Granzhan A; Blondel M
Biochimie; 2023 Nov; 214(Pt A):57-68. PubMed ID: 37473831
[TBL] [Abstract][Full Text] [Related]
33. Immune Evasion by Epstein-Barr Virus.
Ressing ME; van Gent M; Gram AM; Hooykaas MJ; Piersma SJ; Wiertz EJ
Curr Top Microbiol Immunol; 2015; 391():355-81. PubMed ID: 26428381
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.
Fu Q; He C; Mao ZR
J Zhejiang Univ Sci B; 2013 Jan; 14(1):8-24. PubMed ID: 23303627
[TBL] [Abstract][Full Text] [Related]
36. An update: Epstein-Barr virus and immune evasion via microRNA regulation.
Zuo L; Yue W; Du S; Xin S; Zhang J; Liu L; Li G; Lu J
Virol Sin; 2017 Jun; 32(3):175-187. PubMed ID: 28669004
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.
Chang MS; Kim WH
Cancer Res Treat; 2005 Oct; 37(5):257-67. PubMed ID: 19956524
[TBL] [Abstract][Full Text] [Related]
39. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
40. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
